Arlington、VAにおける肥満症の臨床試験
Arlingtonとその周辺地域（約30マイル以内）の拠点で、肥満症に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
被験者募集中第2相
- Washington Center For Weight Management And Research /ID# 282047, Arlington
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
被験者募集中第2相
- Carient Heart and Vascular LLC-Reston, Reston · 14マイル先
- Carient Heart & Vascular - Manassas, Manassas · 22マイル先
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
被験者募集中第3相
- Washington Cntr Weight Mgmt, Arlington
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Manassas · 22マイル先
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
被験者募集中第3相
- Washington Cntr Weight Mgmt, Arlington
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
被験者募集中第3相
- Research Site, Manassas · 22マイル先
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
被験者募集中第3相
- Virginia Heart, Falls Church · 4マイル先
- Inova Cardiology - Fairfax, Fairfax · 11マイル先
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
被験者募集中第3相
- Conquest Research, LLC, Arlington
- Virginia Heart, Falls Church · 4マイル先
- Carient Heart and Vascular, Manassas · 22マイル先
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
被験者募集中第3相
- Manassas Clinical Research Center, Manassas · 22マイル先
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
被験者募集中第3相健康なボランティア歓迎
- ACCOMPLISH-2 Research Site, Burke · 11マイル先
- ACCOMPLISH-2 Research Site, Manassas · 22マイル先
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
被験者募集中第3相
- Kailera Clinical Site, Manassas · 22マイル先
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
被験者募集中第3相
- Washington Center for Weight Management and Research, Inc, Arlington
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
被験者募集中第3相
- Manassas Clinical Research Center Inc, Manassas · 22マイル先
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
被験者募集中第3相
- Kailera Clinical Site, Manassas · 22マイル先
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Arlington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- Conquest Research, Vienna · 9マイル先
- Carient Heart and Vascular, Manassas · 22マイル先
Brief Inhibitory Training for Eating - Intervention
被験者募集中
- George Mason University, Fairfax · 11マイル先
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
被験者募集中第3相健康なボランティア歓迎
- Vanda Investigational Site, Burke · 11マイル先
他の都市における肥満症の試験
- Houston, TX43件の研究
- Chicago, IL41件の研究
- New York City, NY40件の研究
- San Antonio, TX40件の研究
- Washington, DC33件の研究
- Orlando, FL31件の研究
- Dallas, TX30件の研究
- Boston, MA28件の研究
- Las Vegas, NV27件の研究
- Miami, FL27件の研究
- Baltimore, MD25件の研究
- Jacksonville, FL25件の研究
Arlingtonにおける他の研究
- 非小細胞肺癌104件の研究
- 転移性癌53件の研究
- 大腸癌52件の研究
- がん（全種類）48件の研究
- 乳がん46件の研究
- 卵巣がん46件の研究
- 肺がん41件の研究
- 子宮内膜がん39件の研究
- 膵臓がん33件の研究
- 頭頸部扁平上皮癌26件の研究
- 小細胞肺がん23件の研究
- トリプルネガティブ乳がん20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。